Our Conversations Webinar Series is an opportunity to link national experts in colorectal cancer and other related fields to you, right in the comfort of your own home. The programs are designed to empower you to play a leading role in you healthcare management.
Some of the most common side effects we hear about from metastatic colorectal cancer patients on Epidermal Growth Factor Receptor Inhibitors (EGFRI), such as Erbitux (also known as Cetuximab) and Vectibix (also known as Panitumumab), are dry skin, acne and rashes, so on October 21, we hosted our Conversations Webinar “EGFR Inhibitors Rash Management: Prevention Is Key.”
Did you miss the webinar? No problem! Check out these top 6 takeaways and watch the replay.
- Preventing side effects is essential, particularly drying of the skin. It is important to keep the skin moist, because when skin breaks down it can allow bacteria to penetrate. Apply a fragrance-free, dye-free moisturizer to damp skin multiple times throughout the day to help prevent this.
- Limit sun exposure by wearing long-sleeved shirts and pants, as well as hats. Additionally, use sun protection with an SPF of 30 or higher and reapply as recommended.
- Wear rubber or cotton-lined gloves when washing dishes or cleaning and use mild soaps when washing your skin.
- Remember to drink plenty of fluids during treatment!
- If skin reactions occur, give your skin a rest by not shaving your face or legs.
- Keep both your fingernails and toenails clean and dry. Also remember not to bite your nails or cut your cuticles.
This webinar was made possible by support from:
Be sure to download the slides. Don’t forget, the Colon Cancer Alliance serves as a source of information about colon health. If you have additional questions about colon cancer screening or are in need of support, please contact our free Helpline at (877) 422-2030. We’re here to help.